000 02243 a2200637 4500
005 20250515113531.0
264 0 _c20080619
008 200806s 0 0 eng d
022 _a0007-1188
024 7 _a10.1038/bjp.2008.94
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCunha, T M
245 0 0 _aTreatment with DF 2162, a non-competitive allosteric inhibitor of CXCR1/2, diminishes neutrophil influx and inflammatory hypernociception in mice.
_h[electronic resource]
260 _bBritish journal of pharmacology
_cMay 2008
300 _a460-70 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnalgesics
_xpharmacology
650 0 4 _aAnimals
650 0 4 _aArthritis, Experimental
_xcomplications
650 0 4 _aBenzeneacetamides
_xpharmacology
650 0 4 _aCells, Cultured
650 0 4 _aChemokine CXCL1
_xmetabolism
650 0 4 _aChemotaxis, Leukocyte
_xdrug effects
650 0 4 _aCyclooxygenase Inhibitors
_xpharmacology
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aHumans
650 0 4 _aHyperalgesia
_xetiology
650 0 4 _aIndomethacin
_xpharmacology
650 0 4 _aInflammation
_xcomplications
650 0 4 _aInterleukin-8
_xmetabolism
650 0 4 _aMale
650 0 4 _aMesylates
_xpharmacology
650 0 4 _aMice
650 0 4 _aMice, Inbred C57BL
650 0 4 _aMice, Inbred DBA
650 0 4 _aMice, Knockout
650 0 4 _aNeutrophil Infiltration
_xdrug effects
650 0 4 _aNeutrophils
_xdrug effects
650 0 4 _aPain Measurement
650 0 4 _aReceptors, Interleukin-8A
_xantagonists & inhibitors
650 0 4 _aReceptors, Interleukin-8B
_xantagonists & inhibitors
650 0 4 _aReceptors, Tumor Necrosis Factor, Type I
_xgenetics
650 0 4 _aTransfection
700 1 _aBarsante, M M
700 1 _aGuerrero, A T
700 1 _aVerri, W A
700 1 _aFerreira, S H
700 1 _aCoelho, F M
700 1 _aBertini, R
700 1 _aDi Giacinto, C
700 1 _aAllegretti, M
700 1 _aCunha, F Q
700 1 _aTeixeira, M M
773 0 _tBritish journal of pharmacology
_gvol. 154
_gno. 2
_gp. 460-70
856 4 0 _uhttps://doi.org/10.1038/bjp.2008.94
_zAvailable from publisher's website
999 _c17863440
_d17863440